(Q37890996)

24 August 2017

title

Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: a retrospective review of 50 cases (English)

1 reference

24 August 2017

1 reference

Jonathan D Marotti

1

1 reference

24 August 2017

Mary C Schwab

2

1 reference

24 August 2017

Nancy J McNulty

3

1 reference

24 August 2017

James R Rigas

4

1 reference

24 August 2017

Peter A DeLong

5

1 reference

24 August 2017

Vincent A Memoli

6

1 reference

24 August 2017

Gregory J Tsongalis

7

1 reference

24 August 2017

Vijayalakshmi Padmanabhan

8

1 reference

24 August 2017

publication date

16 June 2011

1 reference

24 August 2017

published in

Diagnostic Cytopathology

1 reference

24 August 2017

volume

41

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

15-21

1 reference

24 August 2017

cites work

Cancer statistics, 2010

1 reference

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

21 January 2018

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation.

21 January 2018

1 reference

A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma

21 January 2018

1 reference

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

21 January 2018

1 reference

Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features

21 January 2018

1 reference

Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis.

21 January 2018

1 reference

Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis

21 January 2018

1 reference

Seize the opportunity: underutilization of fine-needle aspiration biopsy to inform targeted cancer therapy decisions

21 January 2018

1 reference

Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas

21 January 2018

1 reference

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

21 January 2018

1 reference

Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas.

21 January 2018

1 reference

Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis

21 January 2018

1 reference

Correlation between morphology and EGFR mutations in lung adenocarcinomas Significance of the micropapillary pattern and the hobnail cell type

21 January 2018

1 reference

Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations

21 January 2018

1 reference

Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer

21 January 2018

1 reference

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

21 January 2018

1 reference

Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma

21 January 2018

1 reference

7 January 2021

Differentiating cytological features of bronchioloalveolar carcinoma from adenocarcinoma of the lung in fine-needle aspirations: a statistical analysis of 27 cases

1 reference

7 January 2021

Bronchioloalveolar carcinoma: diagnostic pitfalls and immunocytochemical contribution

1 reference

7 January 2021

Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer

1 reference

7 January 2021

A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases

1 reference

7 January 2021

Identifiers

DOI

10.1002/DC.21749

1 reference

24 August 2017

1 reference